[{"AccountsPayableCurrent_0_Q3_USD":2951000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-13391000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":18615000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":85000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":61955000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":61955000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":61504000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":4000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":455000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1122000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":245000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":138000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":1743000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":3358000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":548000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":142000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-8866000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":32503000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_3_Q3_USD":229000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":225000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":40000.0,"InvestmentIncomeInterest_3_Q3_USD":1467000.0,"InvestmentIncomeInterest_1_Q3_USD":372000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":382000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":1343000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":2500000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":498000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":54000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":1577000.0,"RepaymentsOfLongTermCapitalLeaseObligations_3_Q3_USD":53000.0,"ProceedsFromStockPlans_3_Q3_USD":214000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":52052000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":45114000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_3_Q3_USD":229000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q3_USD":100000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.09,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1497000.0,"OperatingLeasePayments_3_Q3_USD":535000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":926000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":544000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":592000.0,"OperatingLeaseCost_3_Q3_USD":539000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":314000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":179000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":626000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":331000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":195000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":99000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":402000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1832000.0,"LeaseCost_3_Q3_USD":619000.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":224000.0,"OperatingLeaseLiability_0_Q3_USD":1518000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":8866000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":82000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-9209000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3632000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":212000.0,"NetIncomeLoss_3_Q3_USD":-22532000.0,"NetIncomeLoss_1_Q3_USD":-9291000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-32198000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":6726000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":11583000.0,"LiabilitiesNoncurrent_0_Q3_USD":3426000.0,"LiabilitiesCurrent_0_Q3_USD":9762000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":102935000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":187000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":133000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":9733000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":3068000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.27,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.52,"CommonStockValue_0_Q3_USD":18000.0,"CommonStockSharesOutstanding_0_Q3_shares":17845599.0,"CommonStockSharesIssued_0_Q3_shares":17845599.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":18615000.0,"AssetsCurrent_0_Q3_USD":99005000.0,"Assets_0_Q3_USD":102935000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-1382000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":11422000.0,"ProfitLoss_3_Q3_USD":-22532000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2260000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-115008000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":206119000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":278000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-766000.0,"OtherAssetsNoncurrent_0_Q3_USD":173000.0,"NonoperatingIncomeExpense_3_Q3_USD":9044000.0,"NonoperatingIncomeExpense_1_Q3_USD":3433000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":7332000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":2923000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":136000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":207000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":47000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-21988000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":30709000.0,"OperatingIncomeLoss_3_Q3_USD":-31576000.0,"OperatingIncomeLoss_1_Q3_USD":-12724000.0,"OperatingExpenses_3_Q3_USD":40442000.0,"OperatingExpenses_1_Q3_USD":14301000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":4876000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":17717057.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":17838872.0,"StockholdersEquity_0_Q3_USD":89747000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":11233000.0,"VariableLeaseCost_3_Q3_USD":26000.0,"Ticker":"KALV","CIK":"1348911","name":"KALVISTA PHARMACEUTICALS, INC.","OfficialName":"KalVista Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200131","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339433230.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200310"}]